Compare Duolingo Inc (DUOL) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Stryker Corporation — how do they compare? Duolingo Inc trades at $149.92 (market cap $7.08B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 15× Duolingo Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Stryker Corporation for 21 Days on average.
| DUOL | SYK | |
|---|---|---|
Market Cap | $7.08B | $106.24B |
Volume | 729,171 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $341.08 | $388.35 |
52-Week Low | $90.03 | $269.75 |
Typical Hold Time | 137 Days | 21 Days |
Enterprise Value | $5.85B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $151.22, down 0.33% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue reaching $1.04 billion and net income of $414.07 million, representing a 35.87% net margin. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 surpassing the $0.604 estimate. Technical analysis shows support at $150 and resistance at $152, with the stock trading near recent highs.
Duolingo presents a compelling growth story with strong profitability metrics and consistent earnings beats, though valuation multiples remain elevated. Key risks include insider selling activity and competitive pressures in the edtech space. Analyst consensus leans cautious with 54% hold ratings, but the company's AI-driven content creation and user growth strategy provides long-term upside potential if monetization improves.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
